Blood Reprogramming Technologies

Portugal
Cantanhede, Coimbra, Portugal, 3060 197

Company profile

Blood Reprogramming Technologies company profile

BRT is a biotechnology startup that uses direct cell reprogramming to develop novel hematopoietic stem cell transplantation solutions. Direct cell reprogramming allows the conversion of a mature patient's cell to another specialized cell fate of choice, resulting in the tailoring of functional autologous cells required for cell therapy, drug screening, or disease modeling.

Business identity

Contact email
[email protected]
Phone number
+351 231 249 236
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2017-01-01, Year

Headquarters

Postal code
3060 197
Country code
PT
Continent
Europe

Capital profile

Funding and company signals

Articles
1

Founders and investors

No public relation records are available.